UnknownNot applicableNCT03306940
Botulinum Toxin A in the Treatment of Hemifacial Spasm
Studying Hemifacial spasm
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Tongji University
- Principal Investigator
- Lingjing Jin, PhDShanghai Tongji Hospital, Tongji University School of Medicine
- Intervention
- Botulinum Toxin Type A(drug)
- Enrollment
- 50 target
- Eligibility
- 18-80 years · All sexes
- Timeline
- 2017 – 2018
Study locations (1)
- Shanghai Tongji Hospital, Shanghai, Shanghai Municipality, China
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03306940 on ClinicalTrials.govOther trials for Hemifacial spasm
Additional recruiting or active studies for the same condition.